William R. Ringo - Mar 8, 2022 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
SNSE
Transactions as of
Mar 8, 2022
Transactions value $
$0
Form type
4
Date filed
3/9/2022, 05:24 PM
Previous filing
May 24, 2021
Next filing
May 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Award $0 +8.93K $0.00 8.93K Mar 8, 2022 Direct F1
transaction SNSE Common Stock Award $0 +10K +111.94% $0.00 18.9K Mar 8, 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNSE Stock Option (Right to Buy) Award $0 +29.1K $0.00 29.1K Mar 8, 2022 Common Stock 29.1K $3.08 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in three equal annual installments on each of March 8, 2023, March 8, 2024, and March 8, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
F2 These shares represent RSUs. Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, on March 8, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
F3 Includes 8,933 shares acquired by the Reporting Person as of March 8, 2022 as an RSU award.
F4 The shares subject to the option vest monthly over thirty-six (36) months from the vesting commencement date, March 8, 2022, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.